Study of SHR-7782 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called SHR-7782 for people with advanced cancers that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to provide a sample of your tumor (from a biopsy or past surgery).
- You must have at least one tumor that can be measured on a scan (like a CT scan).
- You should be able to do light housework or sit at a desk (ECOG score 0-1).
- Your major organs (like heart, liver, kidneys) must be working well enough.
- You must not have untreated brain tumors or tumors that have spread to your brain and are causing symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.
This trial is testing a new drug, SHR-7787, combined with other cancer treatments for people with advanced solid tumors that cannot be removed by surgery. The goal is to see if this combination can help shrink or control the cancer.
This trial tests a new drug called SHR-3821 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests an investigational drug called SHR-8203 for people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists. The goal is to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.
This trial tests an experimental drug called SHR-2022 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and helpful.
Hear when a new Advanced Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.